Loading...
Chaoju Eye Care Holdings Limited
2219.HK•HKSE
Healthcare
Medical - Care Facilities
HK$2.75
HK$-0.07(-2.48%)
Chaoju Eye Care Holdings Limited (2219.HK) Financial Performance & Statements
Review Chaoju Eye Care Holdings Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
2.62%
↑ 2.62%
Operating Income Growth
-18.53%
↓ 18.53%
Net Income Growth
-14.78%
↓ 14.78%
Operating Cash Flow Growth
-4.89%
↓ 4.89%
Operating Margin
17.58%
↑ 17.58%
Gross Margin
43.49%
↑ 43.49%
Net Profit Margin
13.88%
↑ 13.88%
ROE
8.41%
↑ 8.41%
ROIC
9.72%
↑ 9.72%
Chaoju Eye Care Holdings Limited (2219.HK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Chaoju Eye Care Holdings Limited stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $335.58M | $335.58M | $367.14M | $367.14M |
| Cost of Revenue | $197.92M | $197.92M | $199.16M | $199.16M |
| Gross Profit | $137.66M | $137.66M | $167.99M | $167.99M |
| Gross Profit Ratio | $0.41 | $0.41 | $0.46 | $0.46 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $97.10M | $97.10M | $85.004M | $85.004M |
| Operating Expenses | $97.10M | $97.10M | $85.004M | $85.004M |
| Total Costs & Expenses | $295.02M | $295.02M | $284.16M | $284.16M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $22.11M | $22.11M | $22.03M | $22.03M |
| EBITDA | $62.67M | $62.67M | $105.01M | $105.01M |
| EBITDA Ratio | $0.19 | $0.19 | $0.29 | $0.29 |
| Operating Income | $40.56M | $40.56M | $82.98M | $82.98M |
| Operating Income Ratio | $0.12 | $0.12 | $0.23 | $0.23 |
| Other Income/Expenses (Net) | $980500.00 | $980500.00 | $6.84M | $6.84M |
| Income Before Tax | $41.54M | $41.54M | $89.82M | $89.82M |
| Income Before Tax Ratio | $0.12 | $0.12 | $0.24 | $0.24 |
| Income Tax Expense | $15.25M | $15.25M | $23.01M | $23.01M |
| Net Income | $29.31M | $29.31M | $68.23M | $68.23M |
| Net Income Ratio | $0.09 | $0.09 | $0.19 | $0.19 |
| EPS | $0.04 | $0.04 | $0.10 | $0.10 |
| Diluted EPS | $0.04 | $0.04 | $0.10 | $0.10 |
| Weighted Avg Shares Outstanding | $727.06M | $727.06M | $687.68M | $687.68M |
| Weighted Avg Shares Outstanding (Diluted) | $694.99M | $694.99M | $687.68M | $687.68M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan